Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa

PROGNOSTIC EVALUATION OF SEVERE SEPSIS AND SEPTIC SHOCK. PROCALCITONIN VERSUS DELTA SOFA

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01841190

Enrollment

128

Registered

2013-04-26

Start date

2012-05-31

Completion date

Unknown

Last updated

2013-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock, Severe Sepsis

Keywords

Prognosis, Sepsis, Septic shock, Procalcitonin, SOFA

Brief summary

The purpose of this study is to compare the tendency of plasma concentration and clearance of procalcitonin in the first 24 and 48 hours of management of patients with severe sepsis and septic shock with another marker of early prognosis represented by 48 hours delta sofa.

Detailed description

This is a cohort prospective observational study that will include adult patients admitted to a multidisciplinary ICU of a tertiary hospital.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients admitted to the ICU * severe sepsis and septic shock

Exclusion criteria

* Children * Pregnant.

Design outcomes

Primary

Measure	Time frame
MORTALITY	28 DAYS

Countries

Brazil

Contacts

Primary ContactJOSE R AZEVEDO, MD

jrazevedo@elo.com.br55 98 32168110

Outcome results